News
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES TEAMS WITH MOREHOUSE SCHOOL OF MEDICINE TO DELIVER DISTANCE LEARNING SOLUTIONS
Groundbreaking Partnership Offers Online Graduate Degree Programs in Public Health and Biotechnology to Over 100,000 Agency Employees and Contractors Atlanta, May 21, 2020 (GLOBE NEWSWIRE)…
Share
Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101
– Trial will evaluate diverse MET dysregulations across broad tumor types – – Focus on non-small cell lung cancer with a mutation that leads to MET exon 14 skipping, and tumors with…
Share
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) — Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its…
Share
FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19
First Patients treated with Organicell Flow through “Emergency Single Patient Compassionate Use” designation MIAMI, May 19, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine, Inc…
Share
CytoDyn and the Mexican National Institutes of Health Participate in a Collaborative Study of Leronlimab for the Treatment of Severe/Critical COVID-19 Population
The study is anticipated to consist of approximately thirty patients with potential involvement of the NIH of Mexico in other CytoDyn trials VANCOUVER, Washington, May 19, 2020 (GLOBE…
Share
CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir
Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir VANCOUVER, Washington, May 18, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the…
Share
CytoDyn to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19
VANCOUVER, Washington, May 15, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020
CytoDyn Submits Requested Datasets to FDA for Biologics License Application VANCOUVER, Washington, May 13, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”)…
Share
Gevo Reports First Quarter 2020 Financial Results
Gevo to Host Conference Call Today at 4:30 p.m. EDT/2:30 p.m. MDTENGLEWOOD, Colo., May 12, 2020 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the first…
Share
Interesting Films and Disabled Hollywood Director Stephan Pacheco Unveil Brand New Movie About Heroic Nurses That Saved the Screenwriter’s Life in This True Story
“Nurses Do It Better” because they doYUMA, Ariz., May 12, 2020 (GLOBE NEWSWIRE) — Film Director Stephan Pacheco unveils “Nurses Do It Better” at select film festivals throughout the world…
Share